blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1174149

EP1174149 - PROLIFERATION INHIBITOR FOR ANDROGEN-INDEPENDENT TUMOR [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  12.09.2008
Database last updated on 14.06.2024
Most recent event   Tooltip12.09.2008Withdrawal of applicationpublished on 15.10.2008  [2008/42]
Applicant(s)For all designated states
KYOWA HAKKO KOGYO CO., LTD.
6-1, Ohtemachi 1-chome Chiyoda-ku
Tokyo 100-8185 / JP
[N/P]
Former [2002/04]For all designated states
KYOWA HAKKO KOGYO CO., LTD.
6-1, Ohtemachi 1-chome
Chiyoda-ku, Tokyo 100-8185 / JP
Inventor(s)01 / TANAKA, Akira
3-1-3-D-303, Gion, Minamikawachi-machi
Kawachi-gun, Tochigi 329-0434 / JP
 [2002/04]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2002/04]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date00917362.619.04.2000
[2002/04]
WO2000JP02544
Priority number, dateJP1999011102619.04.1999         Original published format: JP 11102699
[2002/04]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0062809
Date:26.10.2000
Language:EN
[2000/43]
Type: A1 Application with search report 
No.:EP1174149
Date:23.01.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 26.10.2000 takes the place of the publication of the European patent application.
[2002/04]
Search report(s)International search report - published on:JP26.10.2000
ClassificationIPC:A61K45/00, A61K38/00, A61K39/395, A61K48/00, A61K31/7105, A61K31/711, A61P35/00, A61P43/00, C12Q1/68, G01N33/60, G01N33/15, G01N33/53
[2002/04]
CPC:
A61K38/1709 (EP); A61K31/00 (EP); A61K31/7105 (EP);
A61K31/711 (EP); A61K38/1825 (EP); A61P35/00 (EP);
A61P43/00 (EP); C12Q1/6886 (EP); G01N33/5011 (EP);
C12Q2600/136 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/04]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:PROLIFERATIONSHEMMSTOFF FÜR ANDROGEN UNABHÄNGIGE TUMOREN[2002/04]
English:PROLIFERATION INHIBITOR FOR ANDROGEN-INDEPENDENT TUMOR[2002/04]
French:INHIBITEUR DE PROLIFERATION CELLULAIRE POUR TUMEURS ANDROGENO-INDEPENDANTES[2002/04]
Entry into regional phase09.11.2001Translation filed 
09.11.2001National basic fee paid 
09.11.2001Search fee paid 
09.11.2001Designation fee(s) paid 
09.11.2001Examination fee paid 
Examination procedure02.11.2000Request for preliminary examination filed
International Preliminary Examining Authority: JP
09.11.2001Amendment by applicant (claims and/or description)
09.11.2001Examination requested  [2002/04]
04.09.2008Application withdrawn by applicant  [2008/42]
Fees paidRenewal fee
30.04.2002Renewal fee patent year 03
30.04.2003Renewal fee patent year 04
30.04.2004Renewal fee patent year 05
02.05.2005Renewal fee patent year 06
30.03.2006Renewal fee patent year 07
27.04.2007Renewal fee patent year 08
20.03.2008Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO9419455  (GENENTECH INC [US], et al);
 [Y]WO9406456  (GENENTECH INC [US], et al)
 [X]  - MCPHERSON S.J. ET AL., "Growth inhibitory response to activin A and B by human prostate tumor cell lines, LNCaP and DU145", J. ENDOCRINOL., (1997), vol. 154, no. 3, pages 535 - 545, XP002929639

DOI:   http://dx.doi.org/10.1677/joe.0.1540535
 [A]  - SCHMITT J.F. ET AL., "Expression of fibroblast growth factor-8 in adult rat tissues and human prostate carcinoma cells", J. STEROID BIOCHEM. MOL. BIOL., (1996), vol. 57, no. 3/4, pages 173 - 178, XP002929640

DOI:   http://dx.doi.org/10.1016/0960-0760(95)00259-6
 [A]  - YING SHAO-YAO ET AL., "Expression of activin and activin receptors in PC3 human prostatic cancer cells", INT J. ONCOL., (1995), vol. 6, no. 3, pages 601 - 606, XP000912104
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.